Che Kimberly MBA

Clin-e-cal is a digital health company developing smartphone apps to train and monitor inhaler use, focusing on correct technique and adherence. Using our unique Sound Response, acoustic analysis technology we have launched our first app, Rafi-Tone, aimed at helping young children accept their inhaler and allowing their parents to feel reassured. Rafi-Tone works alongside Able spacer and whistle mask which has been optimised for use with young children. We have several apps in development aimed at coaching correct technique and monitoring adherence with inhalers. Through collaborative development, this technology can provide a complete solution for two of the biggest issues in respiratory medicine in an economic and user-friendly manner.

Rescape has a mission to: -Deliver immersive solutions that deliver significant patient, health economics and equality benefits. -Give every patient in hospital care access to their own VR headset. -Give every patient outside hospital the opportunity to utilise VR care. -Make VR empathy and experience training normal business practice. Rescape’s first product - the now medical device DR.VR® is being used within the NHS, Care Homes and Hospices. DR.VR® is a virtual reality distraction therapy solution that primarily supports pain relief, anxiety/stress and improves patient’s experience. The modular DR.VR® platform is flexible, supporting multiple care and therapeutic pathways including being used within ICU reducing pain, anxiety and assisting in the recovery of patients. The iteration DR.VR® Junior is designed for Paediatric departments and is being used with leading UK Children’s hospitals. The DR.VR® platform is designed to be simple and straightforward to implement even with no prior VR experience. During the pandemic Rescape developed DR.VR® Frontline with a targeted outcome of reducing anxiety of NHS frontline staff. Following a successful feasibility study commercial sales of DR.VR® are now underway. DR.VR® has also been shown delivering a cost effective training solution into the care and blue light services. Rescape is currently focusing on driving adoption within care pathways that can benefit from the impact that DR.VR® can make today and collaborations that build on the DR.VR® platform and technology for future patient benefits tomorrow.

At Hybrid Air Vehicles we are encouraging customers to Rethink the Skies and consider new approaches to solving some of the toughest challenges facing aerospace today. Airlander can take off and land from virtually any flat surface and offers a powerful combination of flexibility, persistence, payload capacity, and efficiency. Airlander is the future of zero-carbon aviation. #RethinkTheSkies

Clin-e-cal is a digital health company developing smartphone apps to train and monitor inhaler use, focusing on correct technique and adherence. Using our unique Sound Response, acoustic analysis technology we have launched our first app, Rafi-Tone, aimed at helping young children accept their inhaler and allowing their parents to feel reassured. Rafi-Tone works alongside Able spacer and whistle mask which has been optimised for use with young children. We have several apps in development aimed at coaching correct technique and monitoring adherence with inhalers. Through collaborative development, this technology can provide a complete solution for two of the biggest issues in respiratory medicine in an economic and user-friendly manner.

Rescape has a mission to: -Deliver immersive solutions that deliver significant patient, health economics and equality benefits. -Give every patient in hospital care access to their own VR headset. -Give every patient outside hospital the opportunity to utilise VR care. -Make VR empathy and experience training normal business practice. Rescape’s first product - the now medical device DR.VR® is being used within the NHS, Care Homes and Hospices. DR.VR® is a virtual reality distraction therapy solution that primarily supports pain relief, anxiety/stress and improves patient’s experience. The modular DR.VR® platform is flexible, supporting multiple care and therapeutic pathways including being used within ICU reducing pain, anxiety and assisting in the recovery of patients. The iteration DR.VR® Junior is designed for Paediatric departments and is being used with leading UK Children’s hospitals. The DR.VR® platform is designed to be simple and straightforward to implement even with no prior VR experience. During the pandemic Rescape developed DR.VR® Frontline with a targeted outcome of reducing anxiety of NHS frontline staff. Following a successful feasibility study commercial sales of DR.VR® are now underway. DR.VR® has also been shown delivering a cost effective training solution into the care and blue light services. Rescape is currently focusing on driving adoption within care pathways that can benefit from the impact that DR.VR® can make today and collaborations that build on the DR.VR® platform and technology for future patient benefits tomorrow.